Ian Mortimer
Chief Executive Officer bei XENON PHARMACEUTICALS INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Ian C.
Mortimer is currently the President, Chief Executive Officer & Director at Xenon Pharmaceuticals, Inc. He is also a Director at Perimeter Medical Imaging, Inc. and Perimeter Medical Imaging AI, Inc. Mr. Mortimer previously served as an Independent Director at Appili Therapeutics, Inc. from 2017 to 2020.
Prior to that, he was the Chief Financial Officer & Executive Vice President at Arbutus Biopharma Corp.
from 2007 to 2013.
Mr. Mortimer holds an MBA from Queen's University and an undergraduate degree from the University of British Columbia.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.03.2024 | 45 602 ( 0,06% ) | 2 Mio $ | 31.03.2024 | |
| 03.04.2024 | 113 333 ( 0,17% ) | 73 440 $ | 31.03.2024 |
Aktive Positionen von Ian Mortimer
| Unternehmen | Position | Beginn |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Chief Executive Officer | 03.06.2021 |
| PERIMETER MEDICAL IMAGING AI, INC. | Director/Board Member | 03.07.2020 |
Xenon Pharmaceuticals USA, Inc.
 Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA. | President | - |
Ehemalige bekannte Positionen von Ian Mortimer
| Unternehmen | Position | Ende |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Director of Finance/CFO | 01.10.2013 |
Perimeter Medical Imaging, Inc.
 Perimeter Medical Imaging, Inc. Medical SpecialtiesHealth Technology Perimeter Medical Imaging, Inc. provides medical services. It develops, patents and commercializes surgical imaging tools that allow surgeons, radiologists, and pathologists to assess microscopic tissue structures during surgical procedures. It offers OTIS Optical Tissue Imaging Console, OTIS Tissue Immobilization System, OTIS Proprietary Imaging Atlas, and Next Generation OTIS AI Tissue Assessment Algorithms. The company was founded by Elizabeth Munro, David Rempel, Andrew Berkeley, Arsen R. Hajian, and Gordon Cheung in 2013 and is headquartered in Toronto, Canada. | Director/Board Member | - |
| APPILI THERAPEUTICS INC. | Chairman | - |
Ausbildung von Ian Mortimer
| Queen's University | Masters Business Admin |
| University of British Columbia | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| XENON PHARMACEUTICALS INC. | Health Technology |
| APPILI THERAPEUTICS INC. | Health Technology |
| PERIMETER MEDICAL IMAGING AI, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Perimeter Medical Imaging, Inc.
Perimeter Medical Imaging, Inc. Medical SpecialtiesHealth Technology Perimeter Medical Imaging, Inc. provides medical services. It develops, patents and commercializes surgical imaging tools that allow surgeons, radiologists, and pathologists to assess microscopic tissue structures during surgical procedures. It offers OTIS Optical Tissue Imaging Console, OTIS Tissue Immobilization System, OTIS Proprietary Imaging Atlas, and Next Generation OTIS AI Tissue Assessment Algorithms. The company was founded by Elizabeth Munro, David Rempel, Andrew Berkeley, Arsen R. Hajian, and Gordon Cheung in 2013 and is headquartered in Toronto, Canada. | Health Technology |
Xenon Pharmaceuticals USA, Inc.
Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA. | Health Technology |
